Hypoglycemic myocardial stunning as cause of cardiogenic shock in a patient with ischemic cardiomyopathy: A case report and review of literature

Khawar Maqsood, Ghazi Mirrani, Nosheen Sarwar, Amatur R. Amarah, Muhammad Rizwan Sardar, Timothy A. Shapiro

Department of Medicine, Baystate Medical Center, Tufts University School of Medicine, Springfield, USA.
Department of Medicine, Division of Cardiology, Lankenau Medical Center, Wynnewood, USA.
Department of Medicine, Division of Internal Medicine, Lankenau Medical Center, Wynnewood, USA.

DOI: 10.4236/crcm.2013.21024                

Abstract

Hypoglycemia is a common complication seen in patients with diabetes mellitus and has been proven to have adverse effects on cardiovascular mortality. Hypoglycemia can potentially lead to worsening of cardiac function in patients with ischemic heart disease. We present a case of cardiogenic shock in a patient with hypoglycemia secondary to insulin accumulation due to worsening renal function with dramatic recovery of shock once his sugars normalized.

Keywords

Chronic Heart Failure; Hypoglycemia; Myocardial Stunning; Ischemic Cardiomyopathy; Cardiogenic Shock

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Adams Jr., K.F., Fonarow, G.C., Emerman, C.L., et al. (2005) ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). American Heart Journal, 149, 209-216. doi:10.1016/j.ahj.2004.08.005
[2]	Abraira, C., Colwell, J.A., Nuttall, F.Q., Sawin, C.T., Nagel, N.J., Comstock, J.P., Emanuele, N.V., Levin, S.R., Henderson, W. and Lee, H.S. (1995) Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM): Results of the feasibility trial: Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care, 18, 1113-1123. doi:10.2337/diacare.18.8.1113
[3]	Dungan, K.M., Binkley, P., Nagaraja, H.N., Schuster, D. and Osei, K. (2011) The effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure. Diabetes/Metabolism Research and Reviews, 27, 85-93. doi:10.1002/dmrr.1155
[4]	DeFronzo, R.A., Hendler, R. and Christensen, N. (1980) Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration. Diabetes, 29, 125-131.
[5]	Galassetti, P. and Davis, S.N. (2000) Effects of insulin per se on neuroendocrine and metabolic counter-regulatory responses to hypoglycaemia. Clinical Science (London), 99, 351-362. doi:10.1042/CS20000022
[6]	Heller, S.R. (2002) Abnormalities of the electrocardiogram during hypoglycaemia: the cause of the dead in bed syndrome? International Journal of Clinical Practice, S129, 27-322.
[7]	Marques, J.L., George, E., Peacey, S.R., Harris, N.D., Macdonald, I.A., Cochrane, T. and Heller, S.R. (1997) Altered ventricular repolarization during hypoglycaemia in patients with diabetes. Diabetic Medicine, 14, 648-654. doi:10.1002/(SICI)1096-9136(199708)14:8<648::AID-DIA418>3.0.CO;2-1
[8]	Koh, H., Nambu, S., Tsushima, M., Nishioheda, Y., Murakami, K. and Ikeda, M. (1984) The effects of insulin on the cardiovascular system in patients with coronary heart disease. Arzneimittelforschung, 34, 185-190.
[9]	Libby, P., Maroko, P.R. and Braunwald, E. (1975) The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion. Circulation, 51, 621-626. doi:10.1161/01.CIR.51.4.621
[10]	Bansal, S., Toh, S.H. and LaBresh, K.A. (1983) Chest pain as a presentation of reactive hypoglycemia. Chest, 84, 641-642. doi:10.1378/chest.84.5.641
[11]	Pladziewicz, D.S. and Nesto, R.W. (1989) Hypoglycemia-induced silent myocardial ischemia. American Journal of Cardiology, 63, 1531-1532. doi:10.1016/0002-9149(89)90025-8
[12]	Nesto, R.W., Phillips, R.T., Kett, K.G., Hill, T., Perper, E., Young, E. and Leland Jr., O.S. (1988) Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: Assessment by exercise thallium scintigraphy. Annals of Internal Medicine, 108, 170-175.
[13]	Deedwania, P.C. and Carbajal, E.V. (1991) Silent myocardial ischemia: A clinical perspective. Archives of Internal Medicine, 151, 2373-2382. doi:10.1001/archinte.1991.00400120019004
[14]	Deanfield, J.E., Shea, M., Ribiero, P., de Landsheere, C.M., Wilson, R.A., Horlock, P. and Selwyn, A.P. (1984) Transient ST-segment depression as a marker of myocardial ischemia during daily life. American Journal of Cardiology, 54, 1195-1200. doi:10.1016/S0002-9149(84)80066-1
[15]	Ohwada, R., Hotta, M., Kimura, H., Takagi, S., Matsuda, N., Nomura, K. and Takano, K. (2005) Ampulla cardiomyopathy after hypoglycemia in three young female patients with anorexia nervosa. Internal Medicine Journal, 44, 228-233. doi:10.2169/internalmedicine.44.228
[16]	Abel, E.D. (2004) Glucose transport in the heart. Frontiers in Bioscience, 9, 201-215. doi:10.2741/1216
[17]	Komniski, M.S. (2011) Interventricular heterogeneity in rat heart responses to hypoxia: The tuning of glucose metabolism, ion gradients, and function. Heart and Circulatory Physiology: American Journal of Physiology, 300, H1645-H1652.
[18]	Liang, G.Y. (2008) Cardiac glucose uptake and suppressed expression/translocation of myocardium glucose transport-4 in dogs undergoing ischemia-reperfusion. Experimental Biology and Medicine, 233, 1142-1148.
[19]	Davey, K.A. (2007) Immunogold labeling study of the distribution of GLUT-1 and GLUT-4 in cardiac tissue following stimulation by insulin or ischemia. Heart and Circulatory Physiology: American Journal of Physiology, 292, H2009-H2019.
[20]	Domenighetti, A.A., Danes, V.R., Curl, C.L., Favaloro, J.M., Proietto, J. and Delbridge, L.M. (2010) Targeted GLUT-4 deficiency in the heart induces cardiomyocyte hypertrophy and impaired contractility linked with Ca(2+) and proton flux dysregulation. Journal of Molecular and Cellular Cardiology, 48, 663-672. doi:10.1016/j.yjmcc.2009.11.017
[21]	Das, U.N. (2003) Insulin: An endogenous cardioprotector. Current Opinion in Critical Care, 9, 375-383. doi:10.1097/00075198-200310000-00007
[22]	von Lewinski, D. (2010) Functional effects of glucose transporters in human ventricular myocardium. European Journal of Heart Failure, 12, 106-113.
[23]	Stanley, W.C., Lopaschuk, G.D. and McCormack, J.G. (1997) Regulation of energy substrate metabolism in the diabetic heart. Cardiovascular Research, 34, 25-33. doi:10.1016/S0008-6363(97)00047-3
[24]	Carley, A.N. and Severson, D.L. (2005) Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochimica et Biophysica Acta, 1734, 112-126. doi:10.1016/j.bbalip.2005.03.005
[25]	Boudina, S. and Abel, E.D. (2007) Diabetic cardiomyopathy revisited. Circulation, 115, 3213-3223. doi:10.1161/CIRCULATIONAHA.106.679597
[26]	Lopaschuk, G.D., Lakey, J.R., Barr, R., Wambolt, R., Thomson, A.B., Clandinin, M.T. and Rajotte, R.V. (1993) Islet transplantation improves glucose oxidation and mechanical function in diabetic rat hearts. Canadian Journal of Physiology and Pharmacology, 71, 896-903. doi:10.1139/y93-136
[27]	Desouza, C., Salazar, H., Cheong, B., Murgo, J. and Fonseca, V. (2003) Association of hypoglycemia and cardiac ischemia: A study based on continuous monitoring. Diabetes Care, 26, 1485-1489. doi:10.2337/diacare.26.5.1485